Kenvue KVUE announced that it has agreed to be acquired by Kimberly-Clark KMB at an enterprise value of roughly $48.7 billion ...
IPC Indice de Precios Y Cotizaciones Ends 0.98% Lower at 62153.30 — Data Talk — Update The IPC Indice de Precios Y Cotizaciones is down 615.88 points or 0.98% today to 62153.30 ...
Dow Jones Top Company Headlines at 7 PM ET: Palantir Revenue Climbs to Another Record as Defense Work Booms | Denny's ... The company said its sales were $1.18 billion in the third quarter for a ...
Dow Jones Top Markets Headlines at 7 PM ET: S&P, Nasdaq Rise to Kick Off November | Embattled ... The S&P 500 and Nasdaq rose, fueled by investor optimism over companies' continued spending spree on ...
Grab now expects revenue for the year at $3.38 billion to $3.40 billion, versus a prior range of $3.33 billion to $3.40 billion. Group adjusted Ebitda climbed 51% on the year to a record $136 million ...
The company raised its full-year guidance as a result of its momentum. Palantir now anticipates around $4.40 billion in revenues for the 2025 fiscal year, up from the $4.14 billion to $4.15 billion ...
We Initiate Coverage on Charter Hall Social Infrastructure REIT With AUD 3.70 FVE and No-Moat Rating
Charter Hall Social Infrastructure REIT is a reincarnation of Folkestone Education Trust, following Charter Hall Group’s acquisition of Folkestone, a smaller property fund manager, in 2019. From a ...
A Starbucks coffee shop in Beijing in April. The U.S. company is selling a stake in its China business to a Chinese private-equity firm. Starbucks Corp. is selling a majority stake in its China ...
Amazon.com Inc. has become the latest company to ink a deal with OpenAI, a move that's sending the stock higher and solidifying its status as an artificial-intelligence winner.
Dollar/Canadian dollar: 1.4057 Canadian dollars per dollar (0.7114 dollar per Canadian dollar) --Today the dollar gained 0.31% vs. the Canadian dollar --Up 0.82% over the last three sessions --Largest ...
Hims & Hers said that the discussions with Novo Nordisk (DK:NOVO.B) are ongoing, that "no definitive agreement" has been reached, and that the two companies may not reach one. Nonetheless, Hims & Hers ...
Shares of Sarepta Therapeutics Inc. plunged in extended trading Monday after the biotechnology company disclosed disappointing drug-trial data, which could lengthen the timeline of the regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results